Cohance Lifesciences Appoints Umang Vohra Executive Chairman

Cohance Lifesciences appoints former Cipla CEO Umang Vohra as Executive Chairman effective May 1 and Group CEO effective May 20, 2026.
Vivek Sharma steps down as Executive Chairman for personal reasons but continues as Advisor for 9 months to ensure smooth transition.
The board's strategic decision aims to leverage Vohra's pharmaceutical industry expertise for Cohance's transformation and growth phase.
Cohance is a technology-driven CDMO platform specializing in complex chemistry, ADCs, oligonucleotides, and advanced API development.